Moomoo AIのまとめ
Allarity Therapeutics announced the appointment of Alexander Epshinsky as its new Chief Financial Officer, effective September 12, 2024, following Joan Y. Brown's resignation. Epshinsky, a CPA with extensive experience in pharmaceutical and biotech companies, will receive a $340,000 annual base salary, RSUs worth $160,000, and a $50,000 signing bonus.The company has amended its At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, increasing the placement shares amount to $50 million. This modification comes as the company plans to resume its financing initiatives after a two-month pause to support its strategic goals and growth plans.Under Epshinsky's employment agreement, he is eligible for an annual bonus of up to 30% of base salary starting 2025, with prorated bonus for 2024. The agreement includes severance provisions of six months' salary for termination without cause or following a change of control.
Allarity Therapeutics announced the appointment of Alexander Epshinsky as its new Chief Financial Officer, effective September 12, 2024, following Joan Y. Brown's resignation. Epshinsky, a CPA with extensive experience in pharmaceutical and biotech companies, will receive a $340,000 annual base salary, RSUs worth $160,000, and a $50,000 signing bonus.The company has amended its At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, increasing the placement shares amount to $50 million. This modification comes as the company plans to resume its financing initiatives after a two-month pause to support its strategic goals and growth plans.Under Epshinsky's employment agreement, he is eligible for an annual bonus of up to 30% of base salary starting 2025, with prorated bonus for 2024. The agreement includes severance provisions of six months' salary for termination without cause or following a change of control.
Allarity Therapeuticsは、Joan Y. Brownの辞任に続き、Alexander Epshinskyを新しいCHIEF FINANCIAL OFFICERに任命したことを発表しました。この任命は2024年9月12日から有効です。Epshinskyは医薬品およびバイオテクノロジー企業での豊富な経験を持つCPAで、年俸は340,000ドル、RSUは160,000ドルの価値があり、サインボーナスが50,000ドル支給されます。同社はAscendiant資本市場との市場発行販売契約を修正し、配分株数を5,000万ドルに増加させました。この修正は、同社が戦略的目標と成長計画を支援...すべて展開
Allarity Therapeuticsは、Joan Y. Brownの辞任に続き、Alexander Epshinskyを新しいCHIEF FINANCIAL OFFICERに任命したことを発表しました。この任命は2024年9月12日から有効です。Epshinskyは医薬品およびバイオテクノロジー企業での豊富な経験を持つCPAで、年俸は340,000ドル、RSUは160,000ドルの価値があり、サインボーナスが50,000ドル支給されます。同社はAscendiant資本市場との市場発行販売契約を修正し、配分株数を5,000万ドルに増加させました。この修正は、同社が戦略的目標と成長計画を支援するために、2か月の休止の後に資金調達の取り組みを再開する計画であることに伴うものです。Epshinskyの雇用契約に基づき、彼は2025年から基本給の最大30%の年次ボーナスを受ける資格があり、2024年のボーナスは按分されます。この契約には、理由なしの解雇または支配権の変更に続く場合、6か月分の給与の退職金条項が含まれています。
役に立った
役に立たない
